Loading…
Advanced Enzyme Technologies (ADVENZYMES)₹282.10−0.74%Biotechnology
At the end of the Jun 2026 quarter, Advanced Enzyme Technologies' shareholders were: promoters 43.30%, FIIs 26.74%, DIIs 4.82%, public 25.14%. Promoter holding is down 0.01 percentage points from 43.31% a quarter earlier. FII holding is up 3.25 percentage points from 23.49% a year earlier. 0.00% of promoter shares were pledged. It had 63,590 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 45.97% | 43.67% | 43.55% | 43.07% | 43.00% | 42.97% | 43.13% | 43.13% | 43.13% | 43.09% | 43.31% | 43.30% |
| FIIs | 22.31% | 22.58% | 23.05% | 12.07% | 12.67% | 12.61% | 11.94% | 23.49% | 25.45% | 25.89% | 25.54% | 26.74% |
| DIIs | 6.55% | 7.04% | 7.62% | 8.14% | 8.08% | 8.23% | 8.25% | 8.51% | 6.47% | 5.56% | 5.46% | 4.82% |
| Public | 25.17% | 26.71% | 25.78% | 36.72% | 36.25% | 36.19% | 36.68% | 24.87% | 24.95% | 25.46% | 25.69% | 25.14% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 72,632 | 73,024 | 68,630 | 65,213 | 66,748 | 67,341 | 65,313 | 67,579 | 69,627 | 68,041 | 66,184 | 63,590 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Vasant Rathi | Promoter | 26.65% | −0.01 |
| Orbimed Asia III Mauritius FVCI Limited | FII | 12.10% | −0.01 |
| Nalanda India Equity Fund Limited | FII | 8.51% | −0.01 |
| Vasant and Prabha Rathi Generation Trust | Promoter | 6.69% | 0.00 |
| Polunin Emerging Markets Small Cap Fund, LLC | FII | 2.44% | +1.13 |
| Rasika Vasant Rathi | Promoter | 2.40% | 0.00 |
| Reshma Namita Rathi | Promoter | 2.35% | 0.00 |
| Rachana Vasant Rathi | Promoter | 2.34% | 0.00 |
| Clarus Capital I | DII | 2.29% | −0.47 |
| Marval Guru Fund | FII | 1.78% | 0.00 |
| Pradip Bhailal Shah | Public | 1.65% | 0.00 |
| Mukund Madhusudan Kabra | Public | 1.64% | 0.00 |
| Kishor Laxminarayan Rathi HUF | Promoter | 0.99% | 0.00 |
| Prabhavati Vasant Rathi | Promoter | 0.82% | 0.00 |
| Madhusudan Kabra | Promoter | 0.55% | 0.00 |
| Kishor Laxminarayan Rathi | Promoter | 0.36% | 0.00 |
| Jayesh Madhusudan Soni | Promoter | 0.01% | 0.00 |
| Megha Jhawar | Promoter | 0.01% | 0.00 |
| Pratik Prakash Kokane | Promoter | 0.01% | 0.00 |
| Shruti Sharad Dhamdhere | Promoter | 0.01% | 0.00 |
| Snehal Shamsunder Soni | Promoter | 0.01% | 0.00 |
| Chandrakumar Laxminarayan Rathi | Promoter | 0.00% | 0.00 |
Promoters held 43.30% of Advanced Enzyme Technologies at the end of the Jun 2026 quarter, up 0.17 percentage points from 43.13% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 26.74% (up 1.20 percentage points from 25.54% a quarter earlier) and domestic institutions (DIIs) held 4.82% (down 0.64 percentage points from 5.46% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Advanced Enzyme Technologies had 63,590 shareholders at the end of the Jun 2026 quarter, against 67,579 a year earlier.
Orbimed Asia III Mauritius FVCI Limited (FII) held 12.10% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.